The food metabolome is defined as the part of the human metabolome directly derived from the digestion and biotransformation of foods and their constituents. With .25,000 compounds known in various foods, the food metabolome is extremely complex, with a composition varying widely according to the diet. By its very nature it represents a considerable and still largely unexploited source of novel dietary biomarkers that could be used to measure dietary exposures with a high level of detail and precision. Most dietary biomarkers currently have been identified on the basis of our knowledge of food compositions by using hypothesis-driven approaches. However, the rapid development of metabolomics resulting from the development of highly sensitive modern analytic instruments, the availability of metabolite databases, and progress in (bio)informatics has made agnostic approaches more attractive as shown by the recent identification of novel biomarkers of intakes for fruit, vegetables, beverages, meats, or complex diets. Moreover, examples also show how the scrutiny of the food metabolome can lead to the discovery of bioactive molecules and dietary factors associated with diseases. However, researchers still face hurdles, which slow progress and need to be resolved to bring this emerging field of research to maturity. These limits were discussed during the First International Workshop on the Food Metabolome held in Glasgow. Key recommendations made during the workshop included more coordination of efforts; development of new databases, software tools, and chemical libraries for the food metabolome; and shared repositories of metabolomic data. Once achieved, major progress can be expected toward a better understanding of the complex interactions between diet and human health.
INTRODUCTION
The 2 major achievements of nutrition research in the 20th century were the discovery of essential nutrients and the elucidation of their role in key physiologic functions. Recommendations were defined to provide adequate intakes of these nutrients that led to reduction in risks of deficiency diseases, at least in high-income Western societies. The past 2 decades have seen a shift in nutrition research away from the prevention of deficiency diseases toward the prevention of chronic diseases and the elucidation of the role of nonessential food constituents on such diseases (1) . This constitutes a considerable challenge for nutrition research in the 21st century, in particular because of the extreme variety of these bioactive constituents and the large diversity of biochemical targets and signaling and metabolic pathways they may interact with.
Although classical hypothesis-driven approaches have been very successful in discovering essential nutrients, they are ill adapted to aid our understanding of the role of highly diverse nonessential compounds in foods. Data-driven approaches and "omics" technologies offer opportunities to explore the complex interactions between diet and the human organism. In particular, the measurement of hundreds or thousands of metabolites in metabolomic experiments now allows the characterization of individual phenotypes with a level of precision never before achieved (2) . Individuals or populations exposed to different environments, lifestyles, or diets can be distinguished and characteristic metabolic differences identified (3) .
A growing number of metabolomic studies have been published over the past 5 y in the field of nutrition (3) (4) (5) (6) . Metabolomics was used to show the alteration of metabolic profiles on the consumption of specific nutrients, foods, or diets in smallscale intervention studies. Two different fractions of the human metabolome are influenced by the diet: the endogenous metabolome and the food metabolome ( Figure 1 ). The endogenous metabolome includes all metabolites from the host. Its variations show novel metabolic effects of the diet that may affect human health. The "food metabolome" has been defined as the sum of all metabolites directly derived from the digestion of foods, their absorption in the gut, and biotransformation by the host tissues and the microbiota as first proposed by one of the authors of this review in 2008 (7) . Other authors have also proposed to define the "food metabolome" as the whole set of food constituents in any foods (5, 8) . A definition of the metabolome centered on biological species is preferred here. Humans consume as many metabolomes as there are biological species making up our foods-for example, the tomato or beef metabolomes. Therefore, the human metabolome contains fractions of these metabolomes, partly transformed after ingestion, which constitute the human food metabolome.
The various foods consumed by humans contain .25,000 compounds, most of them being further metabolized in the human body (9) . The food metabolome is therefore highly complex and also highly variable. This variability constitutes a unique and extremely rich source of information on the human diet that has barely been exploited. Detailed characterization of the food metabolome should permit accurate monitoring of dietary exposure and identification of foods that influence disease risks in clinical and epidemiologic studies. This review describes the current knowledge on the food metabolome and discusses opportunities for nutrition research. It also makes recommendations to move the field forward as discussed by the participants in the First International Workshop on the Food Metabolome (4-5 June 2013, Glasgow, United Kingdom), which convened with 50 experts from Europe and North America (Supplemental Table 1 under "Supplemental data" in the online issue).
DIETARY BIOMARKERS IN THE PRE-OMICS ERA
Studies of connections between the diet or specific dietary factors and health status require accurate measurements of dietary exposures. Such measurements can be used to evaluate compliance in dietary intervention studies, to find associations with disease outcomes, or to monitor dietary changes in populations. Dietary exposure has traditionally been measured with self-reported methods, namely dietary recalls or food-frequency questionnaires (10) . However, a number of random and systematic errors are inherent in such methods, including recall bias and difficulty in assessing portion sizes (11) . The resulting misclassification of subjects, especially when sorting them according to dietary intake, can influence observed associations between dietary exposures and disease outcomes and underlies inconsistencies in published findings in the field of nutritional epidemiology (12) .
To address these shortcomings, intense efforts have been directed toward statistical techniques to correct measurement errors as well as toward developing new dietary assessment instruments. The application of dietary biomarkers as more objective measures of dietary exposure in nutritional epidemiology has been particularly significant (13) . These biomarkers have been used as measures of nutritional status and of exposure to bioactive molecules in foods, as surrogate indicators of food intake, and to validate measures of dietary intake (14) . Biomarkers are also useful when little or no data exist on food composition, as is often the case for bioactive molecules such as glucosinolates or food contaminants such as aflatoxins (15, 16) .
Dietary biomarkers measured in population studies
A variety of dietary biomarkers identified through the analysis of correlations with dietary intake have been measured in epidemiologic studies. Information on these biomarkers has been systematically collected in the novel Exposome-Explorer database (V Neveu, DS Wishart, and A Scalbert, unpublished data, 2014); w100 biomarkers could be identified (Supplemental Table 2 under "Supplemental data" in the online issue). These biomarkers have been measured in plasma or serum (carotenoids, fatty acids, vitamins, polyphenols, food contaminants, and FIGURE 1. The human metabolomes. sp., species. THE FOOD METABOLOME: A WINDOW OVER DIETARY EXPOSURE enzymes), red blood cells (fatty acids, carotenoids, and hemoglobin adducts), and to a lesser extent in urine (polyphenols, vitamins, inorganic compounds, and amino acids). Some of these biomarkers correspond to nutrients and bioactive compounds and have been used to compare status or exposure. Some have been used as surrogate biomarkers of food intake, as follows: polyphenols, carotenoids, and vitamin C for fruit and vegetables (17, 18) ; alkylresorcinols for whole-grain cereals (19, 20) ; isoflavones for soy (21) ; amino acids and fatty acids for meat (22, 23) ; fatty acids for dairy products and fish (22, 24) ; and polyphenols for tea and wine (18, 25) (Table 1) . Dietary biomarkers not only include natural food constituents but also certain food additives such as iodine in milk (26) or food contaminants such as polychlorinated biphenyls in fatty fish (27) . These latter biomarkers are often specific to certain populations who consume these additives or where consistent levels of contamination are observed.
Other biomarkers are directly derived from the digestion and gut absorption of food constituents or are endogenous metabolites that have been altered by exposure to specific nutrients. For instance, serotonin metabolism is altered by acute alcohol intake (28) , the activity of selenium-containing enzymes such as erythrocyte glutathione peroxidase depends on selenium intake, and ceramide synthase is inhibited by exposure to the mycotoxin fumonisins (29) .
Pharmacokinetics and reliability of dietary biomarkers
Dietary biomarkers are not without their limitations. They may be altered because of possible interactions with genetic factors, physiologic or health status (ie, age or obesity) (30) , dietary factors such as fats for lipophilic biomarkers (31) , and lifestyle factors such as alcohol intake or smoking (32) . Their concentrations also vary over time according to their pharmacokinetic properties. A higher intraindividual variability is expected for biomarkers with a short half-life (20, 33) . Intraindividual variability leads to exposure measurement errors when the objective is to characterize habitual exposure in epidemiologic studies and small numbers of measurements are available across subjects.
Some of the biomarkers listed in Table 1 have half-lives that do not exceed 24 h [polyphenols, alkylresorcinols, and amino acids (34, 35) ]. These biomarkers may thus be useful only in populations who regularly and frequently consume these dietary sources. Lipophilic markers (carotenoids, lipids) (36) or biomarkers associated with erythrocytes (folate, fatty acids) (29) have longer half-lives (week to month) because of the equilibrium of biomarkers between blood and fatty tissues, or because of their integration into erythrocytes. Some dietary compounds such as isothiocyanates and acrylamide also form adducts with blood albumin and hemoglobin (37, 38) , with half-lives varying between 3 and 8 wk, and may be used as longer-term biomarkers. Protein adducts with dietary compounds have received limited attention thus far. Adductomics appears to be particularly promising for the discovery of these adduct biomarkers (39, 40) .
Biomarker sensitivity and specificity
Dietary biomarkers should have sufficient sensitivity to measure exposures within ranges commonly found in the populations of interest. Intervention studies are essential to address this question and to evaluate the relation between exposure and biomarker concentrations (17, 41) . Biomarkers such as vitamin C or selenium in erythrocyte glutathione peroxidase show saturable effects and may not be suitable for use at high levels of exposure (29, 42) . Conversely, some biomarkers are present at concentrations too low to be reliably detected at low levels of exposure. For example, some biomarkers of alcohol abuse were not appropriate to evaluate low to moderate levels of alcohol consumption (43) .
Specificity is another essential characteristic of biomarkers. Some biomarkers can be highly specific for a particular food (Table  1) . Proline betaine and lycopene are well-established biomarkers for citrus fruit and tomato products, respectively (44, 45) . Other biomarkers may be common to several foods or characteristic of an entire food group. Vitamin C and a number of carotenoids and flavonoids are common to many fruit and vegetables. Vitamin C or the sum of carotenoids or flavonoids have been used as generic biomarkers for fruit and vegetable intake (18, 45) .
Single biomarker or combinations of biomarkers
Traditionally, single biomarkers have been used to characterize complex dietary exposures such as consumption of a whole food group or intake of a group of compounds with related biological activities. Two examples show the limits of such global assays. Vitamin C used as a biomarker for fruit and vegetable intake is present in a large number of fruit and vegetables, but its content varies widely according to species, varieties, and food-processing methods. It is also widely used as an additive and dietary supplement. The Folin assay, commonly used to estimate total polyphenols in foods (46) , has also been applied to urine samples to compare polyphenol intake (47) , but such use may be inappropriate because of the presence of interfering reducing metabolites in such complex biological matrices (46) .
In contrast to these global assays, analytic approaches based on the estimation of combinations of dietary constituents may provide more accurate measurements of dietary exposure. The ratios of 2 alkylresorcinols characteristic of whole-grain wheat or rye were found to be good indicators of the relative consumption of these cereals (20, 48) . However, there are very few such examples in which combinations of biomarkers were used to improve the specificity of dietary exposure measurements. Metabolomics constitutes a comprehensive approach to identify new panels of biomarkers that are specific or common to particular foods or food groups, as shown recently for citrus fruit (49) . This should greatly improve the assessment of exposure to classes of food bioactive compounds, food groups, or dietary patterns.
THE FOOD METABOLOME IN THE OMICS ERA
Metabolomics can be described as the application of highthroughput analytic chemistry technologies [liquid chromatographymass spectrometry (LC-MS) 4 , nuclear magnetic resonance spectroscopy (NMR), gas chromatography-mass spectrometry (GC-MS)] directed at characterizing the metabolome (ie, the small molecules associated with metabolism). Its development follows that of genomics, transcriptomics, and proteomics. Although not as rapid in development or as high-throughput as its omics cousins, metabolomics led a sea change in how small molecules could and should be analyzed. Rather than being limited to measuring only one or a few compounds at a time, new metabolomic technologies allowed researchers to measure hundreds or even thousands of metabolites at a time. This newly found capacity to measure so many chemicals at once led to a number of metabolomic projects, all launched in the mid2000s, aimed at identifying the metabolomes of microbes (50), plants (51) , and humans (52) (53) (54) . These projects typically used LC-MS, GC-MS, NMR, or a combination of all 3 techniques to identify and/or quantify as many metabolites as possible in cells, tissues, and biofluids of the organisms of interest. These comprehensive metabolomic studies were also complemented by a number of much more specific metabolomic studies aimed at characterizing the metabolic responses of humans to the intake of various foods or food constituents such as soy (55) , citrus fruit (44), nuts (56) , meats (57) , and tea (58).
The food metabolome as part of the human metabolome
It was through these early metabolome studies that scientists realized that the human metabolome was not as small or as simple as first imagined. In particular, noticeable differences in human metabolomes could be detected that appeared to depend strongly on diet, sex, health status, genetics, kinetics, physiology, and age-with diet being most important (59) (60) (61) (62) . This dietary dependence was not unexpected, but it was not anticipated to be so complicated. Unlike laboratory animals, humans are free-living omnivores who, in fact, eat other metabolomes. Furthermore, humans are exposed to a huge variety of "chemical environments" associated with the various foods we consume. Thus, the human metabolome is not just a single entity but consists of several components (Figure 1 ), including the following: 1) the endogenous metabolome (consisting of chemicals needed for, or excreted from, cellular metabolism), 2) the food metabolome (consisting of essential and nonessential chemicals derived from foods after digestion and subsequent metabolism by the tissues and the microbiota), 3) other xenobiotics derived from drugs, and 4) xenobiotics derived from environmental or workplace chemicals.
The exact size and composition of these different human metabolomes are difficult to ascertain. Minimally, the human metabolome contains 50,000 different detectable compounds (9, 63) , but as instrument sensitivity and separation technologies improve, this number is expected to increase. Up to 200,000 different metabolites are estimated to occur in the plant kingdom, and combinations of several hundreds of secondary metabolites generally characterize each edible plant (6, 64, 65) . Furthermore, the composition often depends on the body compartment, tissue, or biofluid to which one refers. For instance, many food or drug constituents that might be found in the mouth or stomach are chemically identical to the compounds isolated from the intact food or drug. On the other hand, food constituents found in blood, urine, or other excreta are often metabolically transformed in the liver, kidney, or intestine to metabolites that are very different from the parent compound. This adds greatly to the diversity of the food metabolome. However, in some cases, the parent compounds are broken down to such an extent that their end products are actually identical to chemicals that the body produces naturally. The importance of the gut microbiota in contributing metabolites to the human metabolome has also recently emerged (50, 66) . Some microbial metabolites, typically vitamins, certain essential amino acids, and a few fatty acids, are specific microbial metabolites (w100 compounds in total are known at this time). However, a large majority of the metabolites produced by the gut microbiota are derived from the biotransformation of both the endogenous metabolome and the food metabolome and are therefore an integral part of these 2 metabolomes. These microbial metabolites include short-chain fatty acids, secondary bile acids, protein and amino acid metabolites, as well as plant polyphenol metabolites (67) .
Metabolism of food constituents
Knowledge of the metabolism of food constituents is critical to understanding the origin of the biotransformed fraction of the food metabolome. It is also essential if we wish to use food metabolites as nutritional biomarkers or as a means to monitor food consumption. In this regard, it is useful to review how food chemicals can be metabolized. Food constituents can be metabolized in 3 different ways: 1) they can be digested in the mouth, stomach, and small intestine into simple nutrients that can be absorbed through the gut barrier; 2) they can be further transformed by host tissues, especially the liver and kidney; or 3) they can be processed by the gut microbiota in the large intestine.
The first category of food constituents are intermediary metabolites formed by digestion of lipids, polysaccharides, and proteins. Most of these compounds are common to all living organisms and identical to human endogenous metabolites. They cannot generally be used as dietary biomarkers because of their common identity and the impossibility to trace their dietary origin. The possible exceptions are the essential amino acids, essential fatty acids along with most vitamins, and minerals, which cannot be produced by humans and must originate from external dietary sources.
The second way that food constituents can be metabolized is through transformation by host tissues. Food compounds that are not useful for basic metabolism or that do not correspond to familiar endogenous metabolites are treated as "foreign" or as xenobiotics. Examples of exogenous food constituents include polyphenols, alkaloids, carotenoids, chlorophylls, artificial colors, artificial flavors, natural volatiles for flavoring/aroma, and Maillard reaction products formed during cooking. The human body maintains a complex defense system consisting of dozens of enzymes and membrane transporters to recognize these foreign and potentially toxic chemicals and to neutralize them by rapid biotransformation and/or elimination. Classically, the biotransformation process consists of 2 types of chemical reactions, phase I and phase II transformations, both of which occur primarily in the liver, kidney, and intestine. Phase I transformations typically involve oxidation of compounds via cytochrome P450 enzymes as well as hydrolysis by various dehydrogenases, esterases, and amidases. On the other hand, phase II transformations consist of chemical modifications such as methylation (by methyltransferases), sulfation (by sulfotransferases), acetylation (by N-acetyltransferases), glucuronidation (by UDP-glucuronyltransferases), and amino acid conjugation (by glutathione or glycyl transferases). A recent meta-analysis (68) of the metabolic fate of .1000 xenobiotics showed that cytochrome P450 catalyzed oxidations (40%) and UDP-glucuronosyltransferase glucuronidations (14%) were the most common followed by reactions involving dehydrogenases (8%), hydrolases (7%), glutathione-S-transferases (6%), and sulfatases (5%). In fact, there are .300 different empirical rules that allow one to predict the fate of metabolites on the basis of their chemical structure (69) . Many of the metabolites derived from the biotransformation of food components have not been well characterized. For polyphenols, .230 phase I/II metabolites have been identified and associated with the consumption of specific polyphenol-containing foods (70) . The yield of phase I/II reactions are often very high (68, 71) , and host-transformed metabolites retain many of the features of their parent compounds. Consequently, these exogenously derived metabolites can be quite useful as specific food biomarkers.
The third way that food metabolites may be transformed is through microbial metabolism. Microbes have a very different set of enzymes from mammals, and given that there are .1000 different species of microbes in the human gut (72) there is an enormous diversity of enzymatic processes that act on foodderived compounds. The gut microbiota is particularly adept at processing polyphenols to phenolic breakdown products. For instance, depending on the predominant microbiota, polyphenols can be transformed by ring cleavage to a variety of aromatic compounds such as benzoate and various derivatives of hydroxyphenylacetic and hydroxypropionic acids. These phenolic acids can be further conjugated to glycine as in hippurate. The gut microbiota also processes indigestible carbohydrates through a variety of fermentative pathways yielding short-chain fatty acids such as butyric acid and propionic acid. Certain microbial metabolites can be useful as food biomarkers, although there is a complex relation between the food source, the predominant gut microbial species, and the resulting food metabolites (73) . Consequently, weaker correlations with intakes of foods or of their constituents were observed for microbial metabolites when compared with untransformed food compounds and host-transformed metabolites (41) . This is most probably a result of the large variability of the microbiota across subjects (74) . As a result, microbial metabolites should be treated with some caution when used as food biomarkers.
Food metabolome and metabolite databases
Given the complexity of food constituents, the diversity of known food metabolites, and the rapidly growing number of studies on the food metabolome, it is becoming clear that wellcurated databases are of utmost importance to keep track of this information. These "omics era" databases are being developed to help researchers understand the origins and fate of many food metabolites ( Table 2) . Some recent examples include the Human Metabolome Database (HMDB) (9) , the E. coli Metabolome Database (ECMDB) (66), the Yeast Metabolome Database (YMDB) (75) , Food Component Database (FooDB) (76), Phenol-Explorer (70), and PhytoHub (77). HMDB is an online database of all known and presumptive human metabolites. This rapidly growing database currently contains .40,000 metabolites including endogenous, microbial, biotransformed, and exogenous/xenobiotic compounds. ECMDB is another online database consisting of 2750 metabolites known to be produced by Escherichia coli. This resource provides a representative estimate of the microbial metabolome that exists within the human gut. YMDB is a database consisting of 1730 metabolites known to be produced by Saccharomyces cerevisae. Given the number of food products (wine, beer, bread) produced by yeast fermentation and given that yeast also lives in the human gut, this database can also provide some useful data with regard to food metabolites and their possible origins and fate. FooDB is a database of .28,000 food constituents, including artificial food additives. Much of the chemical data in FooDB is now in HMDB, but FooDB provides additional information about food sources and food concentrations that is not in the HMDB. PhytoHub is an online database dedicated to the phytochemicals present in plant foods (w1000 compounds), their known human metabolites reported in the literature, and other potential metabolites predicted with in silico expert systems. Phenol-Explorer is an online database providing detailed information on dietary polyphenols and polyphenol metabolites. These food-focused resources are particularly detailed and provide substantially more in-depth information and reference material than what is available in the HMDB, YMDB, and ECMDB resources. Entries in each of these databases mentioned here are linked to other online resources such as PubMed, PubChem, Kyoto Encyclopedia of Genes and Genomes, Chemical Entities of Biological Interest, ChemSpider, and other widely used chemical resources. The establishment of these database resources along with the increasingly widespread use of metabolomics in nutrient analysis has now moved the field of food and nutrition science firmly into the modern "omics" era.
METABOLOMICS AND DISCOVERY OF NOVEL DIETARY BIOMARKERS

Study design
As noted previously, metabolomics has emerged as a key tool in the search for novel biomarkers of dietary intake. To date, the methods used for biomarker discovery can be divided into 2 main categories: hypothesis-driven and data-driven. In both cases, metabolomics-based approaches can be applied. In the hypothesisdriven approach, prior knowledge about the biomarker or a series of biomarker candidates is available from food composition databases such as FooDB (78) and methods are developed to measure the candidate biomarkers. So far, this approach has essentially been applied to specific families of food constituents such as fatty acids or carotenoids (45, 79) .
In the data-driven approach, there is no prior knowledge of the biomarker and a large number of metabolites are measured, with the main limitation being the capacity of the analytic instrument to detect them. This approach has been used to discover novel biomarkers for a number of foods, nutrients, or diets ( Table 3) . The samples to be analyzed can be obtained from 1) controlled dietary interventions or 2) cross-sectional studies.
In controlled dietary interventions, subjects consume the food items of interest in a single meal (acute study) or in repeated meals over a given period of time (ranging from a few days to up to 6 mo; short-to medium-term study). In acute studies, biofluids are collected postprandially over a time period of up to 24 h after consumption of the food of interest. Ideally, any biomarker identified in these acute studies must be validated with an intervention study to ensure there is a dose response, which would render the biomarker suitable for use over a range of intakes. In short-term interventions, biofluids are collected at the end of the intervention period and compared in subjects consuming either the test food or a control food. Biofluids can also be collected before and after consumption of the test food. A limitation of these intervention studies is the fact that the biomarkers identified may not be sufficiently specific for the test food in population studies, because regular diets may include other foods containing precursors of the same biomarkers. For instance, in a crosssectional analysis of a whole-diet intervention study it was only possible to verify 23% of potential biomarkers observed in previous-meal studies (81) .
Cross-sectional studies can therefore play an important role in biomarker discovery. Low and high consumers are selected from food intake data collected by using food-frequency questionnaires, food diaries, or other dietary assessment tools. Comparison of these groups can lead to the identification of biomarkers that are reflective of habitual intake, provided that these biomarkers have a sufficient half-life in the organism or that the foods are regularly consumed. Although these and other studies have shown the potential of cross-sectional studies, care needs to be taken because many of the foods consumed are highly correlated and there is a risk of identifying biomarkers that are not specific to the particular food of interest unless their identity and specific occurrence in the considered foods are established. Notwithstanding, crosssectional studies are excellent resources that are currently underused for dietary biomarker discovery.
Novel dietary biomarkers identified through a metabolomic approach
An extensive list of potential dietary biomarkers discovered by metabolomics is presented in Table 3 . Markers associated with the consumption of foods, nutrients, or diets have been identified. Successful studies include the identification of proline betaine as a marker of citrus intake (49, 80) . This marker was first identified in small-scale acute feeding studies and validated in free-living subjects in 2 independent studies (44, 80) . It was confirmed in a cross-sectional study that used untargeted metabolomics (49) and played an important role in discriminating noncompliant individuals in a dietary pattern study of Nordic compared with habitual diets (106) . In these same studies, screening of urinary profiles for predicted metabolites of citrus fruit also led to the identification of some terpenoids and flavonoids as biomarkers of citrus food intake as well as of intake of citrus-flavored sweets. This shows well the importance of previous knowledge on food composition and on metabolism of food constituents for annotating unknown discriminating ions in untargeted metabolomic studies.
Trimethylamine oxide-N-oxide (TMAO) was found to be a putative biomarker for meat intake or for meat-containing diets in several studies (102) (103) (104) , but it has also been reported as a biomarker of fish intake by other authors (82, 107) and shown to be more responsive to intake of fish than meat (85) . Several dietary precursors of TMAO such as choline or carnitine have been described (108) and care should be paid when interpreting variations in TMAO concentrations in populations.
The state of validation of biomarkers listed in Table 3 varies widely. Proline betaine is a good example of a well-validated citrus fruit biomarker. Other biomarkers, particularly those identified in controlled intervention studies, may prove to be less robust in populations because of the possible existence of a variety of precursors as seen for TMAO, or the occurrence of the same precursor in various foods. Food-derived biomarkers such as caffeic acid sulfate or methylepicatechin sulfate, which were found to discriminate consumers of raspberries (82), may not be that useful in epidemiologic studies because both their parent metabolites (caffeic acid and epicatechin) have been described in a variety of foods of plant origin (70) .
For this reason, it may be particularly advisable to look for characteristic dietary biomarkers directly in cross-sectional studies. However, the chances to identify robust biomarkers will rely both on the sensitivity of the analytic equipment used and on the quality of the dietary data against which metabolic profiles are correlated. Both 24-h dietary recalls and food-frequency questionnaires have been used, and new biomarkers for citrus fruit intake or coffee were successfully identified (49, 88) (Table 3 ). The use of food-frequency questionnaires may directly lead to the identification of biomarkers of habitual dietary exposure, but the lower accuracy and lower number of foods documented may limit their value for such discovery studies (105) .
With the exception of 2 studies on dietary fiber and milk protein diet, all discovery studies were conducted on urine samples as opposed to blood samples ( Table 3 ). The reason for this is partly technical because of the higher concentrations of food-derived metabolites in urine as compared with blood and because of the lack of interfering proteins. This contrasts with the preferred use of blood biospecimens to measure biomarkers of nutritional status in epidemiologic studies. More metabolomic studies using blood samples should be carried out because of the more common availability of plasma or serum samples in biobanks. Also, lipophilic biomarkers, which may be more stable over time (see Pharmacokinetics and reliability of dietary biomarkers section), are more likely to be found in blood. Regression analyses of the concentrations of 363 metabolites in plasma with a number of dietary variables measured with a food-frequency questionnaire showed the highest correlations with phospholipid concentrations (109) . Furthermore, chain length and degree of saturation of fatty acids in glycerophosphatidylcholines were associated with intake of specific foods or nutrients such as fish and dietary fiber.
It is important to point out that the identities of many of the proposed biomarkers in Table 3 (marked with an asterisk) have not been fully validated with proper chemical standards because these standards are often not commercially available. In addition, no standard yet exists to report chemical identification of biomarkers in metabolomic studies (110) . For this reason, it is often difficult to evaluate the degree of confidence in biomarker identification.
Analysis of the food metabolome
Analyzing the food metabolome is a particularly challenging task for 3 reasons. First, it comprises a much greater chemical diversity than any other part of the metabolome (see Food metabolome and metabolite databases section). A second feature of the food metabolome is the huge range of concentrations, from picomolar or nanomolar concentrations for some contaminants or phytochemical metabolites to millimolar concentrations for nutrients such as sugars. Third, many components of the food metabolome are unknown. Indeed, the metabolism for a large proportion of nonnutrients in humans has never been studied and the chemical structures of their circulating metabolites have not been identified. Until recently, the food metabolome was typically analyzed through targeted methods optimized for specific compounds or families of nutrients or nonnutrients, such as THE FOOD METABOLOME: A WINDOW OVER DIETARY EXPOSURE lipids, organic acids, sugars, flavonoids, or carotenoids. However, the combination of available targeted analysis methods is still far from covering the whole chemical space of the food metabolome. In principle, untargeted metabolomics provides a wider coverage and is likely to show the presence of new metabolites in biofluids and tissues. As is the case for the other parts of the metabolome, mass spectrometry (MS) coupled with gas chromatography or liquid chromatography and NMR are currently the most widely used technologies for food metabolome analysis ( Table 3 ). The advantages and disadvantages of these techniques have been extensively discussed elsewhere and are beyond the scope of the present review (111) (112) (113) . Briefly, NMR is robust, nondestructive, and quantitative but has a relatively low sensitivity, which narrows its coverage of the food metabolome to predominant nutrients, sugars, and microbial metabolites present at millimolar to micromolar concentrations. MS is by far the most sensitive technique and the only method able to cover the nonnutrient metabolites of the food metabolome occurring at low concentrations in biological samples. GC-MS combined with chemical derivatization has been used to analyze constituents of the food metabolome such as phenolic acids or fatty acids (79, 93, 94) . However, to date, most studies on the food metabolome have been performed by using high-resolution liquid chromatographyquadrupole-time-of-flight MS with electrospray ionization (Table 3 ). This technique has been successful in detecting compounds such as terpene metabolites, diketopiperazine metabolites, phenylvalerolactones, and benzoxazinoid metabolites, which are interesting candidate biomarkers of food intake that would not be easily detected in biofluids by NMR or GC-MS (49, 86, 96) . No single chromatographic method is able to cover the wide range of polarity existing for the food metabolome compounds. Highly polar compounds may have to be analyzed by using hydrophilic interaction chromatography, whereas specific methods with atmospheric pressure chemical ionization may be developed for profiling apolar plasma metabolites. Direct flow injection-MS has also been used (82, 114) , which offers the advantage of high-throughput analysis, as would be required for large-scale epidemiologic studies. However, ion suppression effects, due to inefficient ionization of certain ions in complex matrices and the inability to discriminate between isomers, limit the use of this approach.
The main current limitation of MS is the very challenging and burdensome task of the structural elucidation of the detected ions (see below). However, because of its sensitivity and breadth of coverage, LC-MS has certainly become the method of choice for untargeted analysis of the food metabolome. Rapid advances in technology have led to a new generation of much more efficient time-of-flight and single-stage Orbitrap (Exactive; Thermo Scientific) instruments, offering improved linearity, resolution, and mass accuracy, which will be critically important for the analysis of the food metabolome (115) . As with any experimentally based analytic method, multiple variables can substantially affect the final data set. These include the mode of sample preparation, method of chromatography, mode of detection, and the choice of data reduction methods (116, 117) . No standardized method exists yet, and the need for improved harmonization is certainly desirable for further progress on the food metabolome.
Achieving absolute quantification rather than relative quantification of food metabolome metabolites via untargeted methods ion cyclotron resonance; GC, gas chromatography; H/L, high and low (intake); H/M/L, high, medium, and low (intake); LC, liquid chromatography; MS, mass spectrometry; NA, not applicable; NMR, nuclear magnetic resonance spectroscopy; P, plasma; Q, quadrupole; S, serum; SMTI, short-and medium-term intervention; Tof, time-of-flight; U, urine.
remains a continuing challenge. It is essentially impossible to use standards or isotopically labeled references to quantify the thousands of compounds in the food metabolome. New approaches are being developed with isotope labeling and multiple reaction monitoring-based profiling for families of compounds sharing distinctive chemical functionalities (118) . Labeled reagents targeted at these functionalities or particular multiple reaction monitoring transitions could be used to specifically measure selected fractions of the food metabolome such as amines, phenols, glucuronides, or mercapturic acid derivatives. These advances may allow researchers to target larger areas of the food metabolome chemical space with the use of standardized quantitative methods.
Analysis of metabolomic data
The metabolic profile of raw data generated by the spectrometric analysis of biological samples can be analyzed in several steps (119, 120) . These include data preprocessing, data alignment, data normalization, and signal correction followed by the analysis through various statistical methods. There are a number of different software tools available for these tasks; most vendors have their proprietary software but highly efficient freeware programs, Web servers, or add-on softwares exist. For NMR, an example is the Interval Correlation Optimized shift algorithm produced for Matlab (121) , and for LC-MS data alignment freeware such as XCMS (122), MZmine (119, 123) , and MetAlign (124) are widely used.
The preprocessing step is software dependent and typically includes data reduction methods such as centroiding of mass spectra or analog-to-digital conversion of NMR, infrared, or UV/ visible spectra. Preprocessing also includes translation of data formats and data export. The next step is data alignment. It is crucial to align the different sample profiles, which do not match exactly because of small variations in retention times, masses, or chemical shifts. All available software tools differ in their peak picking algorithms. There is only a 50-70% overlap between the peaks detected by different packages from the same raw data set, even with similar settings (125) . Additional markers may be observed by using additional softwares or simply by altering software settings. Another major difference between packages is the presence or absence of so-called gap filling, a routine to revisit the raw data for any peak that has not been detected in a sample when it was found in others. The lack of a gap-filling algorithm creates major problems for normalization and for statistical analysis. An ideal food intake marker would have a zero value in control samples from volunteers who did not consume the food; in this case, the gap-filling routine helps to estimate the background noise in the peak area.
The output from the peak detection and data alignment steps is typically a matrix of samples and features with the intensity as the values within the matrix structure. A feature here denotes any distinct peak in the data set, regardless of whether it represents a known, unknown, or even an artifact ion. In LC-MS profiling, the features are characterized by a retention time and a mass (m/z) value. Such a feature may be a compound's parent ion, but just as frequently it represents an adduct ion or a fragment from a compound. In NMR and in most other digitized spectral data the single features are part of spectral shapes that usually have local maxima and minima. For both kinds of data the fine structure of the data contains additional information that is useful for identifying compounds and structures in the samples and is therefore particularly important for characterizing the food metabolome.
Metabolic profiling data may be analyzed by using univariate or multivariate statistical methods. Statistical analysis of untargeted metabolomic data is often an initial step in the biomarker discovery process that should not be confused with hypothesis testing, because there is no a priori hypothesis. In dietary intervention studies with single foods, the contrast observed for a good biomarker can be large, sometimes even infinite, making it possible to work robustly with small sample sets and discriminate potential intake biomarkers from more subtle changes in endogenous metabolites (126) . In cross-sectional studies this large contrast seldom applies, but approximate dose-response relations from food-frequency questionnaires may help in the identification of food intake biomarkers.
Multivariate analysis is most commonly used for explorative analysis of metabolic profiling data (127) . As opposed to univariate analysis, multivariate analysis can be performed in an unsupervised manner (ie, without including information on group assignment for the analysis). This provides an objective assessment of the principal patterns in the data set (eg, intake or no intake of a specific food component or diet). Unsupervised analysis such as principal components analysis (PCA) should always be the starting point for explorative multivariate analysis to ascertain that there is an overall segregation into a food-related pattern. The features associated with any pattern can be shown by the loadings in a PCA plot; however, PCA is generally not well suited to identify the most prominent part of the pattern. Sparse PCA overcomes this limitation (128, 129) . Clustering methods are also widely used for subdividing and ordering a data set into groups of data with a high degree of similarity. Hierarchical clustering generates a dendrogram in which neighboring samples share the greatest similarity and neighboring features are those most closely related. This provides useful biological information and unsupervised groupings of the data set (130) .
Supervised multivariate analysis is commonly the next step in many data analysis methods but has a strong tendency to overfit the data. Even random data will usually segregate and show a "marker pattern" after supervised analysis (131) . Careful validation with the use of techniques such as permutation testing and cross-validation is therefore always necessary. There are a large number of supervised methods (120, 127) , with the most commonly used analysis for comparing 2 groups being partial least-squares discriminant analysis (PLS-DA) (132) or one of its several variants. In complex nutritional studies it may be useful to combine ANOVA separations of factors with PLS-DA (133, 134) or use multilevel PLS-DA to reduce the influence of interindividual variation (135) . Some multivariate methods such as PLS are mainly used to fit the data to a continuous variable. This is useful to explore the relation of any features in the profiling data set with an external variable (eg, intake of a specific food based on a questionnaire or any biological outcome marker) (121) . In addition, for these prediction models very careful validation is required and their global ability to predict a specific food intake has to be assessed in separate studies.
Univariate analysis is supervised-that is, a hypothesis regarding a difference between groups is implicit. Any marker identified by this approach should therefore also be independently validated in a separate study. For univariate analysis used in exploration of new food intake biomarkers it is important to set a reasonable threshold for false discovery rates (FDRs) (136, 137) . In explorative science there is no fixed rule for the acceptability level of the FDR, and any level from 5% to 50% may be useful, depending on further data analysis steps. If no additional data analysis is planned as, for instance, in metabolome-wide association studies (MWASs), the FDR should generally be selected in the lower end of this range. If the univariate data step is used for selection of features that will be analyzed further (eg, by multivatiate models), it may be more appropriate to use a higher FDR. In any case, the markers found must be validated in subsequent independent studies.
Overall, the field of metabolomics is rich with data analysis options, and the challenge in the future will be to optimally apply these to food metabolomic studies. Useful resources exist to help in selecting and using in the most rigorous way appropriate tools for data analysis in a particular project (138) .
Metabolite identification
Metabolite identification in metabolomic studies relies on the comparison of generated spectra with those in curated metabolite databases. However, the vast majority of the food metabolome components are not yet represented in these databases, which makes the elucidation of their structure difficult. As previously described, the identification of candidate dietary biomarkers is complicated by the fact that the majority of food compounds are treated as xenobiotics by the human body in phase I and phase II reactions or undergo fermentation in the colon by the gut microbiota (139) . Despite some increase in their availability over the past few years, these highly diverse metabolites are largely absent from most databases. One exception is Phenol-Explorer, which gives a comprehensive overview of the human and animal metabolites formed from polyphenols (70) .
NMR spectroscopy and MS are the 2 essential tools for elucidation of the structure of unknown metabolites in metabolomic studies (140, 141) . Metabolites such as S-methyl-L-cysteine sulfoxide or proline betaine as biomarkers of cruciferous vegetables or citrus fruit, respectively, could be identified in NMR studies on the basis of their characteristic chemical shifts (Table  3) (80, 84) . More markers of food intake have been identified in MS-based metabolomic studies on the basis of their accurate mass and mass fragmentation spectra (142) (143) (144) .
A number of commercial and "in house" software tools have been developed recently and used to recognize and identify fragments and adducts derived from one food metabolite (97, 114, 145) . These tools are particularly useful to identify phase II conjugates, common constituents of the food metabolome, which show characteristic neutral losses (eg, 79.957 amu for sulfate conjugates and 176.032 amu for glucuronides) (44, 114, 140) . Customized in-house databases on the most likely phase I and phase II metabolites have also been developed based on in silico prediction with expert systems such as Meteor (49, (146) (147) (148) . An important challenge for the future will be the development of a coordinated international effort to extend existing and develop novel software tools and databases allowing the more "intelligent" prediction of the metabolic fate of food constituents.
Spectral databases for the food metabolome
Despite the many initiatives to make spectral data sets available to the scientific community, the publicly accessible existing spectral data are still scattered over numerous Web-based (searchable) databases, printed tables in scientific journals, Excel files in supporting information, and scientific books (140, 149, 150) . As described earlier, the major online chemical resources (typified by PubChem, Kyoto Encyclopedia of Genes and Genomes, and ChemSpider) contain limited information on human metabolites derived from food compounds. Although they are not specific to the food metabolome, these resources are useful for metabolite identification because fragmentation data or NMR signals of known metabolites can be compared with the unknown query to gain structural information. The most comprehensive and best-curated chemical (commercial) database is currently SciFinder, which includes many food metabolome compounds collected from the literature (151) . Recently, a large number of food compounds have been added to the HMDB, which makes searches on the basis of their accurate masses possible (9); however, to date it contains few mass fragmentation spectra useful for food metabolite identification.
The robust and reproducible fragmentation patterns and retention times of volatile metabolites in GC-MS have successfully been used to set up metabolomic workflows that search for possible candidate metabolites in the National Institutes of Standards and Technology library or in-house libraries (152) . Recently, similar approaches have been proposed for LC-MSand NMR-based metabolomic data sets. Spectral databases contain fragmentation spectra obtained in different experimental conditions (eg, several collision energies and different mass spectrometers) to facilitate direct comparison with experimental data (141) . Also, the number of metabolite spectra in Chemspider and HMDB is increasing. Even though not specific to the food metabolome, these resources are particularly useful for metabolite identification because fragmentation data or NMR signals of known metabolites can give structural hints for the unknown query.
Software tools for annotation of the food metabolome
Software tools such as MetFrag, MyCompoundID, MetiTree, and Mass Frontier can handle metabolite fragmentation data and permit library searches for potential candidates using in silico fragmentation predictions of metabolites or comparisons to previously fragmented metabolites or standards (146, (153) (154) (155) . MetFusion combines knowledge from spectral databases such as MassBank with the multitude of candidates generated by fragmenters such as MetFrag (156) .
Software tools have also been developed that integrate metabolite annotation directly within the processing pipeline of LC-MS data (157) . For example, CAMERA is a pipeline for the annotation and analysis of LC-MS data in cooperation with XCMS (158, 159) . Online MS/MS fragmentation, UV spectra, and estimates of partition coefficients based on retention time have been used to further investigate metabolite structures (157, 160, 161) . The MagMA software package recently launched is able to read multistage tandem mass spectral data to add potential candidates based on in silico-predicted fragmentation (162) . In particular, the use of accurate fragmentation mass data as input can enhance the metabolite identification process by selecting the most likely candidates on the basis of similarities in fragmentation pathways and their readily assigned elemental formula with the unknown query metabolite as exemplified by dietary polyphenols (144) . A large number of polyphenol metabolites such as glucuronides of 5-(3#,4#-dihydroxyphenyl)-g-valerolactone and sulfate esters of methylated (epi)catechin could thus be easily annotated and some fully structurally elucidated by using a combination of MS fragmentation and NMR (163) .
Moreover, recently developed bioinformatics approaches aim to narrow the number of possible candidate structures that match with an unknown query metabolite by taking into account the chemical and biological background of the sample (164) . For example, it is more likely that a metabolite excreted in urine is more polar as a result of phase II reactions. This has predictable consequences for its expected mass and chromatographic behavior, which can be used to mine metabolomic data sets. It is expected that these various software tools will be beneficial in the hunt for metabolite entities represented by the food metabolome.
PERSPECTIVES FOR FUTURE APPLICATIONS OF THE FOOD METABOLOME Discovering disease-related dietary factors
MWASs have been proposed as useful tools for discovering low-molecular-weight biomarkers that are predictive of either causal exposures or disease progression (59, 165, 166) . In fact, MWASs can be regarded as a special case of the exposome-wide association study, which investigates disease associations with all exposures to low-and high-molecular-weight compounds (167) . Given the thousands of potentially important exposures to consider, MWASs and exposome-wide association studies move away from knowledge-driven designs that focus on a priori hypotheses about particular exposures toward data-driven designs using untargeted or semitargeted sets of analytes (167) . In either case, potentially useful biomarkers may be identified through rigorous comparisons of quantitative or semiquantitative profiles of biospecimens obtained from subjects with and without a particular disease (59) . Because diets and lifestyle strongly affect the metabolome, any pending disease may lead to reverse causation in MWASs; study design and interpretation must therefore take into account the common responses to early signs of disease in the population under study and other potential confounders.
This biomarker discovery process is shown in Figure 2 . With a focus on the food metabolome and associated biomarkers of potentially causal dietary exposures, the figure includes both semitargeted and untargeted designs. In the semitargeted approach, preliminary cross-sectional studies are developed to connect dietary records with the food metabolome and thereby identify dietary biomarkers that are highly correlated with the consumption of particular foods. A good example of this approach is given by Saadatian-Elahi et al (168) , who correlated food consumption, as determined by 24-h dietary recall, with plasma concentrations of 22 fatty acids determined by gas chromatography in 3000 subjects from the European Prospective Investigation into Cancer and Nutrition cohort. Strong correlations between regional dietary factors and fatty acid concentrations allowed components of the food metabolome to be used as predictor variables in a prospective investigation of gastric cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Three fatty acids-oleic acid, a-linolenic acid, and di-homo-g-linolenic acid-were found to be associated with the risk of gastric cancer (169) . These associations were tentatively explained by either different amounts of dietary intake or differential fatty acid metabolism in cases and controls.
The alternative untargeted approach makes no a priori assumptions regarding sources of exposure that are causal for a particular disease but instead relies on comparisons of comprehensive profiles of metabolomic features between cases and controls to find discriminating exposure biomarkers. Once these exposure biomarkers have been identified, follow-up studies are performed to determine their sources (167) , and those related to dietary factors would be regarded as disease-associated dietary biomarkers (Figure 2) . The agnostic nature of the untargeted design allows all potentially useful biomarkers to be identified, including not only dietary biomarkers but also those related to endogenous factors (including the microbiota), pollution, and drugs as well as biomarkers of disease progression. A good example of the untargeted approach is given by Holmes et al (59) and Bictash et al (166) who used untargeted NMR of .4000 urine specimens from the INTERMAP study to investigate potentially causal factors for high blood pressure across geographically diverse populations. The investigators showed that metabolite concentrations differed substantially between Asian and Western populations, suggesting important effects of diet and related risk factors, including the microbiota, on the risk of coronary artery disease and stroke. Three highly discriminating biomarkers were identified, namely alanine, which was directly correlated with blood pressure, and formate and hippurate, both of which were inversely correlated with blood pressure. All of these discriminatory biomarkers point to dietary sources, sometimes in combination with cometabolism by gut microbiota. For example, alanine is associated with diets that emphasize animal products rather than vegetables, and hippurate has been associated with microbiota colonization of the gut (170) .
A more recent example of the untargeted approach is provided by a series of articles from Stanley Hazen's group at the Cleveland Clinic (108, 171, 172) . In their initial untargeted LC-MS/MS investigation (171), the authors showed that the nutrient choline, along with its major metabolites, betaine and TMAO, were associated with risks of cardiovascular disease, particularly TMAO. Then, by using an elegant set of targeted follow-up studies with the use of a choline challenge as well as characterization and manipulation of microbiota, Hazen and coworkers showed that consumption of foods rich in choline or carnitine, such as eggs, milk, liver, meat, or fish, produced high concentrations of TMAO in both humans and animals who possessed the requisite microbiota for metabolizing choline or carnitine to trimethylamine, the immediate precursor of TMAO (108, 171, 172) . Subjects from a cohort of .2000 patients with cardiovascular disease, who were in the highest quartile for plasma TMAO concentrations, had a .2-fold risk of a heart attack or stroke compared with subjects from the lowest quartile (108, 172) .
Identification of new potentially bioactive food-derived metabolites
The application of metabolomics to foods has allowed the identification of a large variety of novel food constituents that are either naturally present in the food species or formed during food processing (65, 173, 174) . Similarly, the exploration of the food metabolome in human biofluids by means of wide-coverage profiling methods and intermetabolite correlation analysis (175) should show exposures to many nonnutrient food compounds and their metabolites whose presence has not been previously identified. These compounds could also be new bioactive compounds. As an example, the recent description of benzoxazinoids in rye facilitated the identification of some of their metabolites (2,4-dihydroxy-1,4-benzoxazin-3-one, 2-aminophenol sulfate, and hydroxylated phenylacetamides) in urinary metabolic profiles observed after rye bread consumption (86, 114) . These benzoxazinoid metabolites certainly deserve further investigation as potential contributors to the health effects of rye products because of some documented anti-inflammatory, immunoregulatory, and appetite-suppressing properties (176) . This example shows that a better characterization of chemicals contained in a given food should markedly improve our understanding of food-derived exposures and their biological effects.
Metabolomics will help nutrition researchers move away from the reductionist views on health effects of foods that have largely prevailed until today. For many years, health effects associated with a particular food have often been attributed to just 1 or 2 of their constituents on the basis of certain biological properties observed in vitro. Examples include lycopene in tomato, which is thought to prevent prostate cancer; isoflavones in soy products, which may prevent hormone-dependent cancers; and catechins in tea or flavanones in citrus, which may play a role in the prevention of cardiovascular diseases. Although these compounds may actually contribute to the health effects of the food, as has been well demonstrated in intervention studies in which a whole food has been compared with one of its bioactive constituents (177) , their popularity may have overshadowed the contribution of other, lesser known constituents also present in the same food. Metabolomics could potentially reveal these other bioactive constituents, and the approach is already being used in the characterization of multicomponent drugs and herbal medicines (178) . Knowledge of all circulating metabolites is essential to understand the effects of the diet on health, and new metabolites formed from nutrients and other food constituents are continuously being identified, even for widely studied compounds (101, 179) .
The combining of metabolomic with genomic data will also be important to identify dietary compounds causally related to diseases. A number of loci associated with variations in the concentration of endogenous metabolites could be identified in genome-wide analysis studies, and many of these genes were coding for metabolic enzymes (180) (181) (182) . Various enzymes involved in the biotransformation of xenobiotics and dietary compounds also show genetic polymorphisms (183, 184) . The analysis of their variants combined with that of the food metabolome in MWASs may reinforce the associations observed between foodderived metabolites and disease risk as has been previously found for alcohol or folate as disease risk factors (185, 186) . A deeper knowledge of the enzymes involved in the biotransformation of dietary compounds is, however, needed to warrant success of this approach.
Another possible approach to identify food compounds potentially responsible for the activity is the study of longitudinal variations in their concentrations and their associations with particular health outcomes or surrogate health markers in population studies or clinical trials. The kinetics of a metabolite's appearance in plasma after a meal can be related to the kinetics of associated physiologic events. Epicatechin metabolite concentrations in plasma after cocoa intake paralleled the increase of plasma nitroso species concentrations and the vascular response (187) . Overall, the study of the variability in the food metabolome (which permeates all human tissues) and its association with health outcomes should greatly contribute to the identification of the food metabolites responsible for the effects of diet on health and diseases.
NETWORKING AND RECOMMENDATIONS TO MOVE THE FIELD FORWARD
As detailed in the previous sections, food metabolomics requires inputs from specialists from various disciplines, including analytic chemistry, chemometrics, statistics, bioinformatics, nutritional science, and biology. Within one group, it is difficult to cover all the techniques and methods required to perform a comprehensive metabolomic study. Several networking initiatives may help in this respect by providing rapid access to new information and tools. The rapid pace of development in metabolomic profiling techniques makes the role of networks even more important to help absorb and facilitate the use of all of the information. This is supported by creating databases for compound information and spectral data, libraries of chemical standards, algorithms for data analysis, repositories for raw data and metadata, and standardization initiatives to define current good practices. The Metabolomics Standards Initiative (MSI) launched by the Metabolomics Society is an example of such an initiative, and the MSI has already had significant impact on reporting formats in metabolomics (110, 188) .
Further networking initiatives to share knowledge in open discussion or workshops, the sharing of data and standard operating protocols, as well as starting common training initiatives will be important to accelerate progress in the field. A good example of such a sharing network is the European Nutrigenomics Organization, a not-for-profit private organization with academic and private institutional members from all over the world. None of these efforts should be seen as static but rather as a current collective instrument to help in the release of biological information at the level of the metabolome. There are several open-user forums working with the development and application of metabolomic software and standards in general, such as the MSI working groups (189), the Metabolomics Forum (190) , and several others, but none of these relate specifically to the food metabolome. The First International Workshop on the Food Metabolome was a first occasion for all researchers active in the field to meet and make propositions for future research. These propositions are summarized here.
Coordination of dietary studies
The food metabolome is exceedingly complex because it encompasses metabolites derived from as many metabolomes as there are edible species. Therefore, a particularly focused community effort is necessary to reach our ultimate goal of full coverage for all foods and all food metabolites. A large number of studies with different designs will be necessary to validate each dietary marker. For example, many studies have been conducted with oranges (Table 3) , but a broad coverage of all citrus and many other fruit as well as kinetic studies have been necessary to interpret proline betaine as a short-term marker of citrus that is dominated by orange and orange juice intake (80) . Similar work is needed and could be a shared effort for many other food groups, including cruciferous and apiaceous vegetables, pomes, cheeses, meats, fish, and others.
A large concerted action or open-project network would be needed to help prioritize needs for novel markers and focus on areas in which drugs have largely failed and where diet and nutrition show promise to prevent or cure diseases. More discussion is clearly needed between laboratory scientists, nutritionists, and epidemiologists to address this question in a rational way. Such a network might share information on current research plans to avoid redundancy, share known as well as unidentified markers related to specific foods, or even form a shared workflow pipeline for dietary studies, data analysis, and metabolite identification. In addition, the constitution of a database describing resources of high-quality human samples collected in various dietary intervention studies developed for other purposes would also be extremely useful. This information is partly accessible in a database such as ClinicalTrials. gov (191) , but no indication is given on the availability of biospecimens. These samples would prove very useful for biomarker validation purposes and would save a lot of effort and money otherwise needed to replicate such clinical studies. An example of a local, but open, sample repository for experimental studies including nutrition is the CUBE biobank, which covers samples from a single university (www.cube.ku.dk). An umbrella of such local repositories could be one possible way forward to improve reuse of samples for biomarker validation studies.
Software tools
A comprehensive set of software tools has been developed and shared to help the scientific community that covers every step in data processing and analysis. Most of these are not specific to the food metabolome analysis (see Analysis of metabolomic data and Software tools for annotation of the food metabolome sections). However, for the identification of food-derived metabolites, additional software developments are needed, particularly for in silico prediction of the metabolism of compounds found in foods. Some commercial software exists for the pharmaceutical area (192, 193) and covers many phase I and II reactions. However, many compounds in foods have structures that are uncommon in pharmaceuticals. Food constituents may be degraded by specialized enzymes and may also be extensively metabolized by the gut microbiota, so these metabolic pathways need to be covered as well. This work will require a large community effort to develop software to predict structures from all possible metabolites from any food compound, including their conjugates; such a tool could be further combined with software that performs in silico fragmentation to predict daughter ions and additional prediction tools for predicting physicochemical properties such as polarity and hence retention time. Prediction of absorption, distribution, and excretion of the food compounds and of their metabolites would be an additional area that would help the food metabolome community. Systematic in silico-predicted metabolites could also be stored in food metabolome databases.
Databases
The human metabolome database has recently expanded to include compounds found in common foods because these are, at least initially before metabolism, also present within the human body (9) . Databases specific for the food metabolome are still largely missing apart from Phenol-Explorer, a database on all known polyphenol metabolites (70) . The development of similar databases for other classes of food compounds will likely require a coordinated effort from many researchers active in various fields. These databases should provide spectral data for the foodderived metabolites in each class and any information useful for their identification. When not available, in silico-predicted mass fragmentation spectra could be calculated and also stored, as is done in SciFinder (151) . The same databases could additionally allow metabolites to be linked with their food precursors, as well as with their possible dietary sources (70) . The involvement of food scientists will be essential to provide this information.
Study repositories with processed metabolomic data
To shape consensus and create openness in the evolving field of metabolomics, it is important to share data and information on food metabolome studies, as is done in many other biomedical fields (194) (195) (196) . Indeed, for many funding agencies, this is becoming a key condition of funding. One such initiative is the Metabolights database, which aims to shape a fully open-access, shared database for metabolomic studies (197) . Raw and processed data and metadata can be uploaded and curated before deposition into the Metabolights core database, which then makes the information accessible through the Internet. A similar ongoing but conceptually broader initiative is the Nutritional Phenotype Database (dbNP) (198) , initiated by the Nutrigenomics Organization. The dbNP can hold data from several omics platforms, including metabolomics, together with study metadata in a searchable format. It is open access and builds on private accounts for uploading and analyzing data with the possibility of open sharing when data can be released for others. Both dbNP and Metabolights provide several online software tools to help in data curation and analysis.
The storage of searchable, annotated, raw analytic data files with well-documented dietary metadata from human intervention or cross-sectional studies will facilitate the comparison of raw or preprocessed data with previously obtained spectral data of foodderived metabolites. Such a repository that contains all unknowns detected in previous food metabolome studies would be a precious aid to identify the most robust dietary biomarkers. The format of raw analytic data concerning the food metabolome as well as that of the dietary metadata will have to be defined.
Food metabolome reference library
The definitive identification of biomarkers is often hampered by the lack of available chemical standards. The large majority of the components of the food metabolome are not commercially available. The development of a resource to synthesize and distribute chemical standards should be a priority. The development of a shared or federated resource of chemical standards for dietary metabolites will allow researchers to confirm or validate compound identifications. Food scientists and natural product chemists who have isolated from various foods and related products or synthesized these chemicals should be associated with this effort. Biotransformation routes (enzymes, microorganisms) could also be better exploited particularly to synthesize conjugated metabolites.
Standardization initiatives
The MSI, initiated by the Metabolomics Society, has already issued several reference articles on good practice for metabolomic research. The MSI is broad and includes activities by several working groups covering many aspects of metabolomics (189) . However, there is no current standardization initiative for the food metabolome, and the current article is launched as a starting signal for such an initiative to share tools, information, and data sets to help encourage a community-driven advancement of research on the food metabolome.
One of the most needed initiatives is a strategy with associated tools for the validation of food intake biomarkers. In particular, a reference database could integrate all potential markers that can be included into targeted multimetabolite methods; each marker listed could be graded indicating the level of validation: for example, "0" for a newly discovered putative biomarker, "1" for a biomarker with analytic validation including kinetics in the sample type of interest, "2" for a biomarker also validated in a controlled dietary intervention studies as well as in cross-sectional studies, and "3" for a biomarker also confirmed to be in accordance with other markers for the same food or foods.
Training
Finally, education and training in the food metabolome also represent an effort that needs to be shared at all levels, from creating the basic training texts to specialized courses at several academic levels. Several training workshops on metabolomics and nutrition were supported by the Nutrigenomics Organization (112) . However, more sustained and focused support is needed to bring the field of food metabolome research to maturity.
CONCLUSIONS
Recent analyses of the food metabolome with modern analytic and bioinformatic tools have shown the considerable extent of information on dietary exposure contained in human biospecimens. Some proof-of-principle studies have established the feasibility of metabolomic approaches to identify novel dietary biomarkers and suggest that these approaches could greatly expand the field of molecular nutritional epidemiology and contribute to future progress in nutrition research. Propositions made here to define common objectives and priorities, optimize study designs, develop databases and software tools, and promote sharing of data and resources should contribute to bringing this emerging field to maturity. A dialogue between nutritionists, epidemiologists, analysts, chemometricians, statisticians, and bioinformaticians has just begun. It will be essential to build multidisciplinary projects and make sure that the design of future studies is defined and optimized to answer to nutritionists' and epidemiologists' most urgent needs for biomarkers. Major progress in assessing complex dietary exposures at the individual level is expected from these biomarkers. They should also significantly contribute to a better understanding of the complex interactions between diet and human health.
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